NAUT
Price:
$2.4
Market Cap:
$301.35M
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.[Read more]
Industry
Biotechnology
IPO Date
2020-08-07
Stock Exchange
NASDAQ
Ticker
NAUT
According to Nautilus Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.29. This represents a change of -13.69% compared to the average of -4.97 of the last 4 quarters.
The mean historical PE Ratio of Nautilus Biotechnology, Inc. over the last ten years is -1306.76. The current -4.29 PE Ratio has changed -67.17% with respect to the historical average. Over the past ten years (40 quarters), NAUT's PE Ratio was at its highest in in the December 2019 quarter at 48.66. The PE Ratio was at its lowest in in the March 2021 quarter at -50.82.
Average
-1306.76
Median
-7.28
Minimum
-7801.78
Maximum
0.12
Discovering the peaks and valleys of Nautilus Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.72%
Maximum Annual PE Ratio = 0.12
Minimum Annual Increase = -6514967.96%
Minimum Annual PE Ratio = -7801.78
Year | PE Ratio | Change |
---|---|---|
2023 | -5.87 | 66.72% |
2022 | -3.52 | -59.54% |
2021 | -8.70 | -58.22% |
2020 | -20.81 | -99.73% |
2019 | -7801.78 | -6514967.96% |
The current PE Ratio of Nautilus Biotechnology, Inc. (NAUT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.03
5-year avg
-1568.13
10-year avg
-1306.76
Nautilus Biotechnology, Inc.’s PE Ratio is less than C4 Therapeutics, Inc. (-2.80), greater than Kymera Therapeutics, Inc. (-20.45), greater than Foghorn Therapeutics Inc. (-5.38), greater than Revolution Medicines, Inc. (-16.70), less than Century Therapeutics, Inc. (-0.79), less than BioAtla, Inc. (-0.93), less than PMV Pharmaceuticals, Inc. (-1.61), less than Caribou Biosciences, Inc. (-1.23), less than Homology Medicines, Inc. (-0.01), less than Precision BioSciences, Inc. (6.14), greater than Beam Therapeutics Inc. (-14.38), less than MediciNova, Inc. (-0.04), less than Eliem Therapeutics, Inc. (-2.42), less than Molecular Partners AG (-2.50), greater than Champions Oncology, Inc. (-18.21), greater than Cyteir Therapeutics, Inc. (-9.12), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Rezolute, Inc. (-4.94), less than HCW Biologics Inc. (-0.78),
Company | PE Ratio | Market cap |
---|---|---|
-2.80 | $300.00M | |
-20.45 | $2.91B | |
-5.38 | $435.85M | |
-16.70 | $9.55B | |
-0.79 | $102.89M | |
-0.93 | $75.90M | |
-1.61 | $83.31M | |
-1.23 | $182.92M | |
-0.01 | $3.02M | |
6.14 | $55.69M | |
-14.38 | $2.07B | |
-0.04 | $104.47M | |
-2.42 | $342.68M | |
-2.50 | $216.81M | |
-18.21 | $61.85M | |
-9.12 | $108.71M | |
-4.78 | $37.86M | |
-4.94 | $284.50M | |
-0.78 | $29.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nautilus Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nautilus Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nautilus Biotechnology, Inc.'s PE Ratio?
How is the PE Ratio calculated for Nautilus Biotechnology, Inc. (NAUT)?
What is the highest PE Ratio for Nautilus Biotechnology, Inc. (NAUT)?
What is the 3-year average PE Ratio for Nautilus Biotechnology, Inc. (NAUT)?
What is the 5-year average PE Ratio for Nautilus Biotechnology, Inc. (NAUT)?
How does the current PE Ratio for Nautilus Biotechnology, Inc. (NAUT) compare to its historical average?